{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T11:33:25Z","timestamp":1782387205762,"version":"3.54.5"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T00:00:00Z","timestamp":1772409600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T00:00:00Z","timestamp":1775520000000},"content-version":"vor","delay-in-days":36,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Carbapenem-resistant\n                      <jats:italic>Klebsiella pneumoniae<\/jats:italic>\n                      (CRKP) is a critical global health threat, with rising resistance rates and high mortality in bloodstream infections (BSIs). In China, the prevalence of CRKP has increased, particularly in Henan Province, where resistance rates are among the highest. However, regional epidemiological data are limited. In the present study, CRKP-BSI and carbapenem-susceptible\n                      <jats:italic>Klebsiella pneumoniae<\/jats:italic>\n                      BSIs (CSKP-BSI) were investigated, resistance patterns were analyzed, and risk factors for CRKP-BSI and KP-BSI were evaluated. The primary objective was to identify the risk factors for CRKP-BSI, while the secondary objective was to determine the risk factors for in-hospital mortality among patients with KP-BSI.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The present study included patients with KP-BSI who were hospitalized in a tertiary hospital in Henan with 1,800 beds from January 1, 2019, to December 31, 2024. A retrospective analysis of patients with KP-BSI was conducted, and clinical data on patient demographics, comorbidities, and discharge outcomes were collected. Univariate and multivariate regression analyses were performed to identify independent risk factors for CRKP-BSI and in-hospital mortality rates associated with KP-BSI.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 414 patients with KP-BSI were included in the study, comprising 90 patients with CRKP-BSI and 324 patients with CSKP-BSI. The independent risk factors for CRKP-BSI included a history of intensive care unit (ICU) admission (OR\u2009=\u200910.49,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.0002), hospital-acquired infection (OR\u2009=\u20099.34,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.0001), hypertension (OR\u2009=\u20092.85,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.0106), and surgery within 30 days prior to infection (OR\u2009=\u20095.88,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.0002). The overall in-hospital mortality rate was 11.8%. The mortality rates of patients with CRKP-BSI and CSKP-BSI were 21.1% and 9.3%, respectively. The independent risk factors for in-hospital mortality due to KP-BSI were a history of ICU admission (OR\u2009=\u20096.03,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.0001) and the presence of lower respiratory tract infections (OR\u2009=\u20092.44,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.0103).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In this comprehensive study, we identified several critical risk factors for CRKP-BSI, including ICU admission, healthcare-associated infection, hypertension, and recent surgical intervention. Moreover, ICU admission and lower respiratory tract infection were identified as independent predictors of in-hospital mortality in patients with KP-BSI.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical trial number<\/jats:title>\n                    <jats:p>Not applicable.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-026-12960-0","type":"journal-article","created":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T12:47:20Z","timestamp":1772455640000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Risk factors for bloodstream infections and mortality in carbapenem-resistant versus susceptible Klebsiella pneumoniae: a six-year retrospective cohort study"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9421-4901","authenticated-orcid":false,"given":"Debao","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8241-6146","authenticated-orcid":false,"given":"Keyang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongliang","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dandan","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiqi","family":"Pei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongmei","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siwei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhizhong","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nana","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenyao","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junmin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjuan","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,2]]},"reference":[{"issue":"5","key":"12960_CR1","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.jinf.2020.08.039","volume":"81","author":"YT Huang","year":"2020","unstructured":"Huang YT, et al. Klebsiella pneumoniae bacteremia revisited: Comparison between 2007 and 2017 prospective cohorts at a medical center in Taiwan. J Infect. 2020;81(5):753\u20137.","journal-title":"J Infect"},{"issue":"9","key":"12960_CR2","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/S1473-3099(13)70190-7","volume":"13","author":"LS Munoz-Price","year":"2013","unstructured":"Munoz-Price LS, et al. Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases. Lancet Infect Dis. 2013;13(9):785\u201396.","journal-title":"Lancet Infect Dis"},{"issue":"10","key":"12960_CR3","doi-asserted-by":"publisher","first-page":"2505","DOI":"10.1093\/jac\/dkad262","volume":"78","author":"DR Giacobbe","year":"2023","unstructured":"Giacobbe DR, et al. Mortality in KPC-producing Klebsiella pneumoniae bloodstream infectionss: a changing landscape. J Antimicrob Chemother. 2023;78(10):2505\u201314.","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"12960_CR4","first-page":"627","volume":"24","author":"Y Guo","year":"2024","unstructured":"Guo Y, et al. CHINET 2023 China antimicrobial resistance surveillance. China Infect Chemother J. 2024;24(6):627\u201337.","journal-title":"China Infect Chemother J"},{"key":"12960_CR5","unstructured":"National Bacterial Resistance Monitoring Network. 2023 National bacterial resistance monitoring report (short version). https:\/\/www.carss.cn\/Report."},{"issue":"3","key":"12960_CR6","doi-asserted-by":"publisher","first-page":"e0419722","DOI":"10.1128\/spectrum.04197-22","volume":"11","author":"S Wang","year":"2023","unstructured":"Wang S, et al. Genomic Epidemiology and Characterisation of Carbapenem-Resistant Klebsiella pneumoniae in ICU Inpatients in Henan Province, China: a Multicenter Cross-Sectional Study. Microbiol Spectr. 2023;11(3):e0419722.","journal-title":"Microbiol Spectr"},{"key":"12960_CR7","unstructured":"\u015eim\u015fek BT, et al. Bloodstream infectionss caused by carbapenem-resistant Klebsiella pneumoniae: analysis of risk factors, treatment responses and mortality. Infect Dis (Lond). 2024:1\u201311."},{"issue":"1","key":"12960_CR8","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s13756-020-00728-3","volume":"9","author":"Y Li","year":"2020","unstructured":"Li Y, et al. Five-year change of prevalence and risk factors for infection and mortality of carbapenem-resistant Klebsiella pneumoniae bloodstream infections in a tertiary hospital in North China. Antimicrob Resist Infect Control. 2020;9(1):79.","journal-title":"Antimicrob Resist Infect Control"},{"key":"12960_CR9","doi-asserted-by":"publisher","unstructured":"Martinez RM, Wolk DM. Bloodstream infectionss. Microbiol Spectr. 2016;4(4). https:\/\/doi.org\/10.1128\/microbiolspec.DMIH2-0031-2016. PMID: 27726765.","DOI":"10.1128\/microbiolspec.DMIH2-0031-2016"},{"key":"12960_CR10","unstructured":"Clinical and Laboratory Standards Institute. Performance standards for antimicrobial- susceptibility testing. 2023, M100\u2013S33."},{"key":"12960_CR11","unstructured":"US Food and Drug Administration, Food US, Administration D, SpringSilver MD. 2019:310.US[EB\/OL][2023-12-01]. https:\/\/www.fda.gov\/drugs\/development-resources\/tigecycline-injection-products."},{"key":"12960_CR12","unstructured":"The European committee on antimicrobial susceptibility testing. Breakpoint tables for interpretation of mics and zone diameters.version 9.0. 2019. Available from: http:\/\/www.eucast.org. Accessed Sep 23 2020."},{"issue":"3","key":"12960_CR13","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","volume":"18","author":"AP Magiorakos","year":"2012","unstructured":"Magiorakos AP, Srinivasan A, Carey RB, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. ClinMicrobiol Infect. 2012;18(3):268\u201381.","journal-title":"ClinMicrobiol Infect"},{"issue":"17","key":"12960_CR14","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.12056\/j.issn.1006-2785.2022.44.17.2022-1056","volume":"44","author":"JN Duan","year":"2022","unstructured":"Duan JN, Zhou YQ, Xu JL, et al. Clinical distribution and resistance analysis of multidrug-resistant Klebsiella pneumoniae bloodstream infectionss. Zhejiang Med J. 2022;44(17):1859\u201362. https:\/\/doi.org\/10.12056\/j.issn.1006-2785.2022.44.17.2022-1056.","journal-title":"Zhejiang Med J"},{"issue":"1","key":"12960_CR15","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1186\/s12866-024-03465-4","volume":"24","author":"Y Cheng","year":"2024","unstructured":"Cheng Y, Cheng Q, Zhang R, Gao JY, Li W, Wang FK, He ZX, Sun QQ, Meng HB, Yu S. Retrospective analysis of molecular characteristics, risk factors, and outcomes in carbapenem-resistant Klebsiella pneumoniae bloodstream infectionss. BMC Microbiol. 2024;24(1):309. https:\/\/doi.org\/10.1186\/s12866-024-03465-4. PMID: 39174950; PMCID: PMC11340057.","journal-title":"BMC Microbiol"},{"key":"12960_CR16","doi-asserted-by":"publisher","first-page":"641","DOI":"10.2147\/IDR.S342103","volume":"15","author":"Z Cao","year":"2022","unstructured":"Cao Z, Yue C, Kong Q, Liu Y, Li J. Risk Factors for a Hospital-Acquired Carbapenem-Resistant Klebsiella pneumoniae Bloodstream infections: A Five-Year Retrospective Study. Infect Drug Resist. 2022;15:641\u201354. PMID: 35241916; PMCID: PMC8887613.","journal-title":"Infect Drug Resist"},{"issue":"10","key":"12960_CR17","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.3760\/cma.j.issn.2095-4352.2019.10.003","volume":"31","author":"Chinese Society of Critical Care Medicine and Chinese Society of Infectious Diseases","year":"2019","unstructured":"Chinese Society of Critical Care Medicine and Chinese Society of Infectious Diseases. Expert consensus on the clinical application of polymyxins in China. Chin J Crit Care Med. 2019;31(10):1194\u20138. https:\/\/doi.org\/10.3760\/cma.j.issn.2095-4352.2019.10.003.","journal-title":"Chin J Crit Care Med"},{"key":"12960_CR18","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.cmi.2021.11.025","volume":"28","author":"M Paul","year":"2022","unstructured":"Paul M, Carrara E, Retamar P, et al. European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant gram-negative bacilli (endorsed by European society of intensive care medicine). Clin Microbiol Infect. 2022;28:521\u201347.","journal-title":"Clin Microbiol Infect"},{"key":"12960_CR19","doi-asserted-by":"crossref","unstructured":"Tamma PD, Aitken SL, Bonomo RA, et al. Infectious Diseases Society of America 2023 Guidance on the treatment of antimicrobial resistant gram-negative infections. Clin Infect Dis. 2023:ciad428.","DOI":"10.1093\/cid\/ciad428"},{"key":"12960_CR20","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.jgar.2019.09.006","volume":"21","author":"J Li","year":"2020","unstructured":"Li J, et al. Risk factors for carbapenem-resistant Klebsiella pneumoniae infection: A meta-analysis. J Glob Antimicrob Resist. 2020;21:306\u201313.","journal-title":"J Glob Antimicrob Resist"},{"issue":"10","key":"12960_CR21","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.11816\/cn.ni.2023-221889","volume":"33","author":"Y Shi","year":"2023","unstructured":"Shi Y, Zhu M, Du M, et al. Risk factors for carbapenem-resistant Klebsiella pneumoniae infections in ICU patients. Chin J Nosocom Infect. 2023;33(10):1473\u20136. https:\/\/doi.org\/10.11816\/cn.ni.2023-221889.","journal-title":"Chin J Nosocom Infect"},{"key":"12960_CR22","doi-asserted-by":"publisher","unstructured":"Xiaona Xie X, Cai T, Wan, et al. Epidemiology of nosocomial carbapenem-resistant Klebsiella pneumonia bloodstream infections in South China: factors related to the patient mortality [preprint]. Research Square. 2020 Jan 29 (Version 1) available at: [ https:\/\/doi.org\/10.21203\/rs.2.22227\/v1 ].","DOI":"10.21203\/rs.2.22227\/v1"},{"key":"12960_CR23","doi-asserted-by":"publisher","first-page":"1339910","DOI":"10.3389\/fcvm.2024.1339910","volume":"11","author":"J Li","year":"2024","unstructured":"Li J, Zhong Q, Yuan S, Zhu F. Global burden of stroke attributable to high systolic blood pressure in 204 countries and territories, 1990\u20132019. Front Cardiovasc Med. 2024;11:1339910. https:\/\/doi.org\/10.3389\/fcvm.2024.1339910. PMID: 38737709; PMCID: PMC11084284.","journal-title":"Front Cardiovasc Med"},{"issue":"3","key":"12960_CR24","doi-asserted-by":"publisher","first-page":"e1004301","DOI":"10.1371\/journal.pmed.1004301","volume":"21","author":"NR Waterlow","year":"2024","unstructured":"Waterlow NR, et al. Antimicrobial resistance prevalence in bloodstream infections in 29 European countries by age and sex: An observational study. PLoS Med. 2024;21(3):e1004301.","journal-title":"PLoS Med"},{"issue":"1","key":"12960_CR25","doi-asserted-by":"publisher","first-page":"30","DOI":"10.12138\/j.issn.1671-9638.20255445","volume":"24","author":"HUANG Shanshan","year":"2025","unstructured":"Shanshan HUANG, Bowen SHI, Dandan WEI, et al. Mo lecular epidemiological study on ST11 carbepenem-resistant hypervirulent Klebsiella pneumoniae in a general hospital in Jiangxi Province [J]. Chin J Infect Control. 2025;24(1):30\u20136. https:\/\/doi.org\/10.12138\/j.issn.1671-9638.20255445.","journal-title":"Chin J Infect Control"},{"issue":"1","key":"12960_CR26","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1186\/s12877-022-03153-w","volume":"22","author":"Y Chen","year":"2022","unstructured":"Chen Y, Chen Y, Liu P, et al. Risk factors and mortality for elderly patients with bloodstream infections of carbapenem-resistant Klebsiella pneumoniae: a 10-year longitudinal study. BMC Geriatr. 2022;22(1):452. https:\/\/doi.org\/10.1186\/s12877-022-03153-w.","journal-title":"BMC Geriatr"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-12960-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-12960-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-12960-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T13:37:20Z","timestamp":1775569040000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-026-12960-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,2]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["12960"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-12960-0","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,2]]},"assertion":[{"value":"29 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in compliance with the ethical principles outlined in the Declaration of Helsinki. The research protocol received formal approval from the Institutional Review Board (IRB) of Jiaozuo People\u2019s Hospital (Approval Number: 2024-038-K38). All the authors reviewed and approved the final manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"732"}}